Lisa Spiguel
DIR & CLIN PROFESSOR
MD-SURGERY
GRANTS
- GRANTSilent Highways: Targeting the Lymphatic Network to Halt Breast Cancer MetastasisFlorida Breast Cancer Foundation30 Jul 2026 - 30 Jun 2027
- GRANTAssessing Benefits and Harms of Medical Cannabis and Cannabinoid Use in Breast Cancer Patients During and After TreatmentsNational Institute of Health Nci1 Mar 2024 - 31 Aug 2028
- GRANTA RANDOMIZED PHASE III TRIAL COMPARING AXILLARY LYMPH NODE DISSECTION TO AXILLARY RADIATION IN BREAST CANCER PATIENTS (cT1-3 N1) WHO HAVE POSITIVE SENTINEL LYMPH NODE DISEASE AFTER NEOADJUVANT CHEMOTHERAPYBreast Cancer Research Foundation10 Sep 2021 - 26 Jan 2025
- GRANTA RANDOMIZED PHASE III TRIAL COMPARING AXILLARY LYMPH NODE DISSECTION TO AXILLARY RADIATION IN BREAST CANCER PATIENTS (cT1-3 N1) WHO HAVE POSITIVE SENTINEL LYMPH NODE DISEASE AFTER NEOADJUVANT CHEMOTHERAPY#Breast Cancer Research Foundation10 Sep 2021 - 9 Sep 2026
- GRANTA RANDOMIZED PHASE III TRIAL COMPARING AXILLARY LYMPH NODE DISSECTION TO AXILLARY RADIATION IN BREAST CANCER PATIENTS (cT1-3 N1) WHO HAVE POSITIVE SENTINEL LYMPH NODE DISEASE AFTER NEOADJUVANT CHEMOTHERAPYNational Institute of Health Nci1 Oct 2020 - 28 Feb 2026
- GRANTA Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer (E2108)National Institute of Health Nci26 Mar 2019 - 28 Feb 2025
- GRANTARM: Axillary reverse mapping—A prospective trial to study rates of lymphedema and regional recurrence after sentinel lymph node biopsy and sentinel lymph node biopsy followed by axillary lymph node dissection with and without axillary reverse mappingNational Institute of Health Nci26 Mar 2019 - 28 Feb 2026
- GRANTA Randomized Phase III Trial of the Value of Early Local Therapy for the Intact Primary Tumor in Patients with Metastatic Breast Cancer (E2108)National Institute of Health13 Aug 2014 - 20 Sep 2019